Cargando…
Metformin - For the dermatologist
Metformin though primarily an antidiabetic drug, has found to play an important role in a number of cutaneous disorders. Because of its role in improving hyperinsulinemia, it has proven beneficial in hormonal acne, hidradenitis suppurativa (HS) and acanthosis nigricans. Its antiandrogenic properties...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4778205/ https://www.ncbi.nlm.nih.gov/pubmed/26997714 http://dx.doi.org/10.4103/0253-7613.174388 |
_version_ | 1782419422113169408 |
---|---|
author | Bubna, Aditya Kumar |
author_facet | Bubna, Aditya Kumar |
author_sort | Bubna, Aditya Kumar |
collection | PubMed |
description | Metformin though primarily an antidiabetic drug, has found to play an important role in a number of cutaneous disorders. Because of its role in improving hyperinsulinemia, it has proven beneficial in hormonal acne, hidradenitis suppurativa (HS) and acanthosis nigricans. Its antiandrogenic properties further serve as an add-on to the conventional management of hirsutism associated with polycystic ovarian syndrome. Very recently, systemic usage of metformin for psoriasis and cutaneous malignancies has shown promising results. Interestingly, metformin has also been topically used in hyperpigmentary disorders with pertinent levels of improvement and happens to be the most recent addition to the list of dermatologic indications. Though an oral hypoglycemic agent to begin with, metformin today has proven to be a boon for dermatologists. |
format | Online Article Text |
id | pubmed-4778205 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-47782052016-03-18 Metformin - For the dermatologist Bubna, Aditya Kumar Indian J Pharmacol Educational Forum Metformin though primarily an antidiabetic drug, has found to play an important role in a number of cutaneous disorders. Because of its role in improving hyperinsulinemia, it has proven beneficial in hormonal acne, hidradenitis suppurativa (HS) and acanthosis nigricans. Its antiandrogenic properties further serve as an add-on to the conventional management of hirsutism associated with polycystic ovarian syndrome. Very recently, systemic usage of metformin for psoriasis and cutaneous malignancies has shown promising results. Interestingly, metformin has also been topically used in hyperpigmentary disorders with pertinent levels of improvement and happens to be the most recent addition to the list of dermatologic indications. Though an oral hypoglycemic agent to begin with, metformin today has proven to be a boon for dermatologists. Medknow Publications & Media Pvt Ltd 2016 /pmc/articles/PMC4778205/ /pubmed/26997714 http://dx.doi.org/10.4103/0253-7613.174388 Text en Copyright: © Indian Journal of Pharmacology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Educational Forum Bubna, Aditya Kumar Metformin - For the dermatologist |
title | Metformin - For the dermatologist |
title_full | Metformin - For the dermatologist |
title_fullStr | Metformin - For the dermatologist |
title_full_unstemmed | Metformin - For the dermatologist |
title_short | Metformin - For the dermatologist |
title_sort | metformin - for the dermatologist |
topic | Educational Forum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4778205/ https://www.ncbi.nlm.nih.gov/pubmed/26997714 http://dx.doi.org/10.4103/0253-7613.174388 |
work_keys_str_mv | AT bubnaadityakumar metforminforthedermatologist |